Alongside being expensive to produce, it also has poor bioavailability compared with injectable semaglutide
A breakthrough for the field came in 1999 when Lohmann et al
Rotate injection sites weekly and space injections 1-2 cm apart within each site to prevent lipohypertrophy and ensure consistent medication absorption
Serious, life-threatening allergic reaction
Learn more at: www.digbihealth.com Ranjan Sinha 29 September, 2023 Digbi Health features in the Top 10 Startups of LGs Mission for the Future challenge Chosen Mission for the Future Companies and LG to Jointly Pursue Innovative Solutions for Digital Health, the Metaverse and Electric Mobility
These entrants are leveraging strengths in peptide synthesis, low-cost biologics manufacturing, and regulatory agility to shorten development cycles and undercut price points, potentially halving or even reducing cost to one-tenth of current therapy levels